A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis
Clinical trial NCT02757352 · COMPLETED
Trial details
- NCT number
- NCT02757352
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-02
- Primary completion
- 2019-03-01
- Enrollment
- 303
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.